• Revenue grew 8% year-over-year to $1.29 billion
• Operating income increased 14% to $426 million
• Net income rose 21% to $365 million
• Strong cash flow generation, with $932 million in cash on hand

ResMed Inc. reported its financial results for the third quarter of fiscal year 2025. The company's revenue grew 8% year-over-year to $1.29 billion, driven by solid performance across both its Sleep and Breathing Health and Residential Care Software segments. Operating income increased 14% to $426 million, reflecting the company's focus on operational efficiency and disciplined cost management. Net income rose 21% to $365 million, demonstrating ResMed's ability to translate top-line growth into enhanced profitability. The company continued to generate strong cash flow, ending the quarter with $932 million in cash and cash equivalents on its balance sheet. These results highlight ResMed's resilience and ability to navigate the evolving healthcare landscape, as it remains committed to delivering innovative solutions and driving value for its customers and shareholders.